Clinical trials
Gallbladder Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University College, London | 3 |
| AstraZeneca | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Jazz Pharmaceuticals | 2 |
| The Christie NHS Foundation Trust | 2 |
| Cancer Research UK | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Helsinn Healthcare SA | 1 |
| Imperial College Healthcare NHS Trust | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 22 |
| Biliary Tract Neoplasms | 11 |
| Cholangiocarcinoma | 11 |
| Bile Duct Neoplasms | 6 |
| Ovarian Neoplasms | 3 |
| Camurati-Engelmann Syndrome | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.